Career Center

This position affords the exciting opportunity to be part of a research effort at Dana-Farber Cancer Institute aiming to delineate genomic aberrations in cancer biology and discover novel therapeutic targets. He/she will use modern next generation sequencing techniques to characterize genomic, transcriptional and epigenetic aberrations with a heavy focus on preparing samples for next-generation sequencing and computational analysis of the resulting datasets. He/she will use various model systems to test for drug responses and determine mechanisms of resistance to drugs, including novel immunotherapies. He/she will be part of a multi-disciplinary team that evaluates new technologies and approaches to discover and validate novel systemic cancer biology.The candidate is expecte